((R)-1-{(S)-2-[(1-Benzoyl-pyrrolidine-2-carbonyl)-amino]-propionylamino}-ethyl)-[2-((S)-3-methyl-1-phenylcarbamoyl-butylcarbamoyl)-4-phenyl-butyl]-phosphinic acid

InChIKey	`NQIXDTDBVQANSX-XZVIONEGSA-N`
Compound Name	((R)-1-{(S)-2-[(1-Benzoyl-pyrrolidine-2-carbonyl)-amino]-propionylamino}-ethyl)-[2-((S)-3-methyl-1-phenylcarbamoyl-butylcarbamoyl)-4-phenyl-butyl]-phosphinic acid
Canonical SMILES	`CC(C)C[C@H](NC(=O)C(CCc1ccccc1)CP(=O)(O)[C@H](C)NC(=O)[C@H](C)NC(=O)C1CCCN1C(=O)c1ccccc1)C(=O)Nc1ccccc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	7.7
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08254	MMP3	Homo sapiens	Human	PF00045 PF00413 PF01471	7.7	Ki	ChEMBL;BindingDB
Q9ULZ9	MMP17	Homo sapiens	Human	PF00045 PF00413 PF01471	7.7	pIC50	TTD_MultiTarget
P18843	nadE	Escherichia coli (strain K12)	Pathogen	PF02540	7.7	pIC50	TTD_MultiTarget